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General practice variation when initiating
long-term prescribing of proton pump
inhibitors: a nationwide cohort study
P. F. Haastrup1*, S. Rasmussen1, J. M. Hansen2, R. D. Christensen1, J. Søndergaard1 and D. E. Jarbøl1
Abstract
Background: Suggestions of overprescribing of proton pump inhibitors (PPIs) for long-term treatment in primary
care have been raised. This study aims to analyse associations between general practice characteristics and
initiating long-term treatment with PPIs.
Methods: A nationwide register-based cohort study of patients over 18 years redeeming first-time prescription for
PPI issued by a general practitioner in Denmark in 2011. Patients redeeming more than 60 defined daily doses
(DDDs) of PPI within six months were defined first-time long-term users. Detailed information on diagnoses,
concomitant drug use and sociodemography of the cohort was extracted. Practice characteristics such as age and
gender of the general practitioner (GP), number of GPs, number of patients per GP, geographical location and
training practice status were linked to each PPI user. Logistic regression analysis was used to determine associations
between practice characteristics and initiating long-term prescribing of PPIs.
Results: We identified 90 556 first-time users of PPI. A total of 30 963 (34.2 %) met criteria for long-term use at six
months follow-up. GPs over 65 years had significantly higher odds of long-term prescribing (OR 1.32, CI 1.16-1.50),
when compared to younger GPs (<45 years). Furthermore, female GPs were significantly less likely to prescribe
long-term treatment with PPIs (OR 0.87, CI 0.81-0.93) compared to male GPs.
Conclusions: Practice characteristics such as GP age and gender could explain some of the observed variation in
prescribing patterns for PPIs. This variation may indicate a potential for enhancing rational prescribing of PPIs.
Keywords: General practice variation, Proton pump inhibitors, Prescribing patterns
Background
Prescribing of proton pump inhibitors (PPIs) has increased
significantly over the past decades and the vast majority is
redeemed in primary care [1]. An increasing number of
patients appear to be treated with PPIs for longer periods
of time [1], and it has been stated that PPIs are prescribed
and continued for questionable reasons [2–4]. Guidelines
to promote rational management of patients with
dyspepsia and rational prescribing of PPIs have been in-
troduced [5, 6], but do not seem to have influenced the
increasing prescribing substantially [1].
Patients are prescribed increasing quantities of PPI on
an empirical background when initiating treatment [7].
A few weeks of treatment can cause acid rebound
hypersecretion and acid related symptoms after with-
drawal [8, 9]. Therefore, prescribing of PPIs for ambigu-
ous reasons for more than a few weeks entails the risk of
creating a vicious circle increasing the need for PPIs.
Hence, moderation when initiating PPI treatment for
unclear reasons is warranted.
Several factors might influence the prescribing pat-
tern of PPIs. It has been demonstrated that patient-
related factors have some impact on the prescribing
of PPIs [7, 10, 11], but physician-related factors might
be of importance as well. Studies have shown that
general practice characteristics such as practice size,
organisation in partnership or single-handed practices,
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the degree of urbanisation and having training prac-
tice status influence management of patients [12–17].
How general practice factors are associated with initiating
long-term treatment with PPIs have not been analysed.
Identifying practice characteristics of importance for initi-
ating long-term PPI therapy may have implications for fu-
ture organisation of primary care services and can help
develop targeted interventions to enhance rational pre-
scribing. Therefore, the aim of this study was to analyse
associations between practice characteristics and initiation
of long-term treatment with PPIs.
Methods
This study is a register-based cohort study of the en-
tire Danish population of approximately 5.6 million
people and all general practices in Denmark (approxi-
mately 2200 practices [18]). The Danish health care
system is tax-funded, and more than 98 % of the in-
habitants are registered with a GP, who acts as gate-
keeper, performing initial diagnostics and treatment
and referring patients to secondary care when re-
quired. All citizens have free and equal access to
health care services [18].
All inhabitants are assigned a unique civil registration
number, and each general practice is registered with
their own identification number. These identification
numbers enable accurate linkage of patients and general
practices through all national registers [19].
Patient cohort sampling
In the Danish National Prescription Register [20] we identi-
fied all individuals over 18 years redeeming a prescription
for PPI in 2011. The date of the first redemption of PPI in
2011 was defined the index date. In order to include only
incident PPI users, patients having redeemed PPIs within
six years prior to the index date were excluded. The cohort
was followed for six months, and similar to other studies
[21, 22], patients redeeming >60 DDDs within six months
were defined incident long-term users (Fig. 1). Patient fac-
tors in terms of gastrointestinal morbidity [23], use of ul-
cerogenic medication [23], general comorbidity [10] and
socioeconomic status [10, 11] have in previous studies been
associated with use of PPIs. Therefore, we retrieved add-
itional data on diagnoses from the Danish National Patient
Register [24], the Danish National Prescription Register and
data on income, cohabitation status and highest attained
education from sociodemographic registers contained in
Statistics Denmark [25, 26]. Drugs were defined as comedi-
cation, if the patient had redeemed a quantity covering the
date of redeeming the PPI. Morbidity was analysed as
gastrointestinal morbidity (diagnoses of peptic ulcer, gastro-
oesophageal reflux disease (including oesophagitis), func-
tional dyspepsia) and as general comorbidity measured by
the Charlson Comorbidity Index [27].
General practice data
The prescriptions for PPI were linked to the prescriber
through the Danish National Health Service Provider
First-time users of PPI 
in 2011: N=124 133
First-time users of PPI 
where therapy was 
initiated in general 
practice: N=90 556
Therapy not initiated in 
general practice: N=33 757
Lost to follow-up: N=3475
Long-term users (>60 DDDs): N=30 963 Short-term users (≤60 DDDs): N= 56 118
First-time users 
available for follow-up: 
N=87081 
Fig. 1 Flow-chart of patient cohort sampling
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Register. We extracted data on the general practices pre-
scribing PPIs to the cohort of first-time users. The average
list size of a typical Danish GP is 1600 patients [18], and
practices with atypical small list sizes (<500 patients) were
excluded, because they were thought not to be representa-
tive (Fig. 2). Practices with missing data in 2010 or 2011
were omitted as well, as this indicates that these practices
were established or closed in that period (Fig. 2).
We identified the number of doctors registered at each
practice and catagorised them as established GPs or tem-
porary doctors. Doctors not registered in the entire period
were defined temporary doctors. Practices were defined
single-handed practices, if only one established GP was
registered, and partnership practice if two or more estab-
lished GPs were registered. The majority of temporary
doctors in general practice are junior doctors having a six-
to twelve-month residency, and practices with these
doctors listed were defined training practices. We calcu-
lated the number of patients per GP by dividing the prac-
tice’s patient list size by the number of established GPs
within the practice. In single-handed practices the age and
gender of the GP were retrieved, and in partnership prac-
tices we calculated the mean age of the established group
of GPs and assessed, whether the group of established
GPs comprised exclusively men or women, predominantly
men or women or equally mixed.
The postcode of all practices was extracted. Practices
within the greater Copenhagen postcode area were cate-
gorised as capital area practices. Practices outside the cap-
ital area, but in a postcode comprising a city with more
than 10 000 inhabitants, were labelled provincial city prac-
tices. All other practice locations were categorised as rural
[28]. According to Danish legislation neither the individ-
ual GP nor the individual patient should be identifiable for
the researchers. Therefore, a few practices (N = 4) with
postcode comprising less than three other practices had
missing postcode and could not be characterised accord-
ing to degree of urbanisation.
For each practice we calculated a “long-term user propor-
tion” defined as the proportion of incident users of PPIs
within the practice who fulfilled the criteria for long-term
use six months after the initial prescription (>60 DDD).
Statistics
The analyses were conducted both with the entire co-
hort of general practices and with stratification into
single-handed and partnership practices. This was
done because the variables age and gender were exact
values in single-handed practices, but average values in
partnership practices. Mixed effects logistic regression
models with patients nested within practice were used
to calculate odds ratios (ORs) with 95 % confidence
intervals (CI) for associations between long-term pre-
scribing of PPIs and practice characteristics. Two re-
gression models were used. Model one estimated the crude
OR for the association of each practice characteristic and
prescribing of long-term treatment with PPIs. Model two
estimated the OR for each practice characteristic, adjusted
for both patient characteristics and other practice charac-
teristics included in the analyses. Patient characteristics ad-
justed for were age, gender, gastrointestinal morbidity,
socioeconomic status (income, highest attained education
and cohabitation status), comedication with non-steroidal
anti-inflammatory drugs (NSAIDs), antiplatelet drugs, anti-
coagulants, selective serotonine reuptake inhibitors (SSRIs)
and comorbidity [7].
A sensitivity analysis with a definition of long-term use
increased to 90 DDDs within six months was performed
in order to explore the consistency of the associations
when changing threshold for long-term use.
General practices initiating PPI therapy in 
87 081 first-time users in 2011: N=2128 
General practices excluded due to atypical 
small list size (<500 patients): N=65
General practices excluded due to missing 
data: N=144
Representative general practices initiating PPI 
therapy in 87 081 first-time users in 2011:  
N=1919
Fig. 2 Flow-chart of sampling of general practices initiating PPI therapy in first-time users in 2011
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P-values <0.05 were considered statistically significant
associations. All analyses were performed using STATA12
(STATACorp, College Station, TX, USA).
Ethics
According to “The Act on Research Ethics Review of
Health Research Projects in Denmark” this register-based
study did not require approval by the Research Ethics
Committee. The study was approved by the Danish Data
Protection Agency, J. nr. 2012-41-0280. Neither patients
nor GPs were identifiable in the dataset.
Results
We identified 124 133 adult first-time users of PPI in
2011. For 90 556 (72.9 %) of the first-time users the pre-
scription for PPI was issued in general practice. Six
months after initial redemption of PPIs the cohort was
subdivided into short-term and long-term users (Fig. 1).
A total of 3475 individuals were lost to follow-up, be-
cause they had either died or moved abroad within the
six months. Hence, their use of PPI in the observation
period could not be assessed and they were excluded. A
total of 30 963 (35.5 %) of the 87 081 first-time users
starting therapy initiated in general practice and avail-
able for follow-up met criteria for long-term use (the
“long-term user proportion”) (Fig. 1).
The prescriptions for PPI to the cohort of first-time
users derived from 2128 general practices. A total of 65
practices were excluded due to atypical small list size
(<500 patients). A total of 144 practices were excluded
due to missing data, indicating that they might have
been established or closed down in 2010 or 2011 (Fig. 2).
Characteristics of the 1919 representative practices initi-
ating PPI therapy were obtained.
The distribution of the “long-term user proportion”
among general practices is illustrated in Fig. 3 and
demonstrates a large variation among practices in the pro-
portion of patients redeeming more than 60 DDDs of PPI
within six months after starting PPI treatment.
Table 1 illustrates the general practice characteristics
and the corresponding mean “long-term user proportion”.
When comparing all general practices, univariate re-
gression analyses revealed that initiating long-term treat-
ment with PPIs was significantly associated with GPs
being male, 55 years and above, single-handed practice
and practicing in rural locations (Table 2).
Only GPs being male and aged 55 years and above
were independently and significantly associated with ini-
tiating long-term treatment with PPIs in the adjusted
analyses (Table 2). These associations remained statisti-
cally significant, when stratifying the analyses into
single-handed and partnership practices, except for GP
age group in single-handed practices where only age of
60 years and above was significantly associated with ini-
tiating long-term treatment with PPIs (Tables 3 and 4).
Similar associations were found in the sensitivity analysis
with the definition of long-term use increased to >90
DDDs within six months, i.e. increasing the threshold
for long-term use changed neither the direction nor the
magnitude of the associations substantially.
In the stratified analyses, a positive association be-
tween training practice status and initiating long-term
treatment with PPIs was statistically significant for part-
nership practices (OR 1.08, CI 1.02-1.14).
Discussion
Main findings
Male gender and increasing age of GPs are significantly
associated with initiating long-term treatment with PPIs
in a cohort of first-time users treated in a primary care
setting. However, general practice characteristics do not
seem to be strong predictors of initiating long-term
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Fig. 3 Distribution of the long-term user proportion among general practices in total numbers (N = 1919)
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treatment with PPIs as the magnitude of the associations
is modest. The apparent variation with regard to rurality
and partnership status observed in the crude analyses
was no longer statistically significant when adjusting for
practice- and patient-related factors. Given that the pa-
tient population in rural and single-handed practices is
older and has a higher degree of morbidity [29, 30], this
might reflect a different composition of patient popula-
tions in different practice types and locations.
Strengths and limitations
The major strength of this study is the register-based design
enabling us to include information on all GPs issuing first-
time prescriptions of PPI to a nationwide cohort of incident
Table 1 Distribution of prescriber characteristics within the entire general practice cohort. The mean and standard deviation (SD) of
the variable “long-term user proportion”* is reported for each prescriber characteristic
N all practices Mean (SD) N single-handed Mean (SD) N partnership Mean (SD)
Practice organisation
Single-handed 1041 0.37 (0.15) 1041 0.37 (0.15) 0 -
Partnership 878 0.33 (0.09) 0 - 878 0.33 (0.09)
Training practice
No 1286 0.36 (0.14) 823 0.37 (0.16) 463 0.33 (0.10)
Yes 633 0.35 (0.11) 218 0.36 (0.14) 415 0.34 (0.09)
Number of GPs
1 1041 0.37 (0.15) 1041 0.37 (0.15) 0 -
2 414 0.33 (0.11) 0 - 414 0.33 (0.11)
3 246 0.33 (0.09) 0 - 246 0.33 (0.09)
4 129 0.33 (0.08) 0 - 129 0.33 (0.08)
5 56 0.33 (0.08) 0 - 56 0.33 (0.08)
>5 33 0.33 (0.06) 0 - 33 0.33 (0.06)
GP age group
Under 45 years 121 0.32 (0.11) 48 0.33 (0.14) 73 0.31 (0.09)
45-49 years 261 0.32 (0.09) 68 0.33 (0.11) 193 0.31 (0.08)
50-54 years 455 0.33 (0.11) 150 0.33 (0.14) 305 0.32 (0.09)
55-59 years 497 0.36 (0.13) 285 0.36 (0.15) 212 0.34 (0.09)
60-64 years 385 0.39 (0.16) 313 0.39 (0.16) 72 0.38 (0.11)
65 years or above 200 0.40 (0.15) 177 0.40 (0.15) 23 0.40 (0.13)
GP gender
Male 875 0.38 (0.15) 735 0.38 (0.15) 140 0.38 (0.11)
Predominantly male 193 0.34 (0.08) 0 - 193 0.34 (0.08)
Equally mixed 302 0.32 (0.09) 0 - 302 0.32 (0.09)
Predominantly female 153 0.32 (0.08) 0 - 153 0.32 (0.08)
Female 396 0.33 (0.14) 306 0.34 (0.15) 90 0.30 (0.09)
Practice location
Capital area 602 0.34 (0.14) 412 0.36 (0.15) 190 0.32 (0.11)
Provincial city 760 0.35 (0.13) 388 0.37 (0.16) 372 0.32 (0.09)
Rural area 557 0.37 (0.12) 241 0.39 (0.15) 316 0.35 (0.09)
Patients per GP
<1350 575 0.35 (0.13) 192 0.38 (0.16) 383 0.33 (0.10)
1350-1575 453 0.36 (0.14) 249 0.38 (0.17) 204 0.34 (0.09)
1576-1750 414 0.35 (0.13) 247 0.37 (0.16) 167 0.33 (0.08)
>1750 477 0.35 (0.13) 353 0.36 (0.13) 124 0.32 (0.10)
*The “long-term user proportion” is defined as the proportion of adult first time users of PPI within the practice who redeemed more than 60 DDDs of PPI within
six months in 2011
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PPI users. The validity of the register data is considered
high [20], and the accurate linkage between the patient-
related factors and the practice characteristics makes it pos-
sible to adjust for numerous predisposing patient factors
and thereby isolate and analyse the independent associa-
tions between practice characteristics and initiation of long-
term treatment with PPIs. Only 3 % of the total sale of PPI
in Denmark is over-the-counter [1], and therefore registra-
tion of PPI use is considered almost complete.
The fact that we extracted practice data at the time of
initiating long-term treatment with PPIs provides the
study with the strength to accurately identify factors of
the physician responsible for initiation of long-term pre-
scribing and to characterise practice features as predic-
tors for incident long-term prescribing. In case we had
analysed practice characteristics associated with preva-
lent long-term prescribing of PPIs, we would not have
been able to be sure of the validity of the predictors,
Table 2 Crude and adjusted odds ratios (ORs) with 95 % confidence intervals (CI) for the associations between characteristics of all
general practices and initiating long-term treatment with PPIs
Crude OR (95 % CI) P-value Adjusted OR* (95 % CI) P-value
Patients per GP
<1350 1 . 1 .
1350-1575 1.03 (0.96;1.10) 0.43 1.00 (0.93;1.07) 0.90
1576-1750 1.00 (0.94;1.08) 0.92 1.01 (0.94;1.09) 0.74
>1750 1.01 (0.94;1.08) 0.83 1.00 (0.93;1.07) 0.94
Geography
Capital area 1 . 1 .
Provincial city 1.01 (0.95;1.07) 0.73 1.02 (0.96;1.09) 0.52
Rural area 1.11 (1.04;1.19) <0.001 1.04 (0.97;1.11) 0.23
GP gender
Male 1 . 1 .
Predominantly male 0.81 (0.75;0.87) <0.001 0.88 (0.78;1.01) 0.07
Equally mixed 0.77 (0.72;0.82) <0.001 0.83 (0.76;0.91) <0.001
Predominantly female 0.76 (0.70;0.83) <0.001 0.87 (0.76;1.00) 0.04
Female 0.77 (0.71;0.82) <0.001 0.87 (0.81;0.93) <0.001
GP age group
Under 45 years 1 . 1 .
45-49 years 1.02 (0.91;1.13) 0.79 0.99 (0.88;1.11) 0.86
50-54 years 1.06 (0.95;1.17) 0.29 1.01 (0.91;1.12) 0.89
55-59 years 1.21 (1.09;1.34) <0.001 1.12 (1.00;1.24) 0.04
60-64 years 1.44 (1.29;1.61) <0.001 1.30 (1.16;1.46) <0.001
65 years or above 1.46 (1.29;1.65) <0.001 1.32 (1.16;1.50) <0.001
Number of GPs
1 1 . 1 .
2 0.86 (0.81;0.92) <0.001 1.04 (0.95;1.13) 0.40
3 0.83 (0.78;0.89) <0.001 1.00 (0.88;1.14) 0.99
4 0.83 (0.76;0.91) <0.001 1.05 (0.92;1.19) 0.50
5 0.85 (0.75;0.96) 0.01 1.01 (0.84;1.20) 0.94
>5 0.84 (0.72;0.98) 0.03 1.01 (0.83;1.22) 0.94
Training practice
No 1 . 1 .
Yes 0.98 (0.93;1.03) 0.36 1.04 (0.98;1.09) 0.20
*Estimates adjusted for all other practice characteristics and patient characteristics in terms of age, gender, specific gastrointestinal morbidity, socioeconomic status (income,
educational level, cohabitation status), comedication with non-steroidal anti-inflammatory drugs (NSAIDs), antiplatelet drugs, anticoagulants, selective serotonine reuptake
inhibitors (SSRIs) and comorbidity
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because prevalent long-term prescribing might have been
established several years earlier by another physician.
However, influence of unmeasured factors cannot be
ruled out. The linkage between the prescription and the
physician factors can only be made at practice level, im-
peding identification of the GP within partnership prac-
tices primarily providing care to the patient. This
limitation makes it difficult to assess the effects of doctors’
age and gender in partnership practices. Exact information
on age and gender would have been more precise than the
mean age of doctors within the practice and the relative
gender distribution. Therefore, the associations between
long-term prescribing of PPIs and GP age and gender can
only be certain for single-handed practices, though the as-
sociations seem similar for partnership practices.
Other potential influential variables could have been in-
teresting to include in the analyses had they been available.
Practice characteristics such as distance to outpatient
clinics (i.e. endoscopy, gastroenterological expertise etc.)
could influence prescribing of PPIs. However, data on prac-
tice location are limited to postcodes in order to keep the
individual prescriber unidentifiable, and the exact address is
not available to calculate distance to outpatient clinics.
Interpretation of findings in relation to previously
published studies
To the best of our knowledge no other study has investi-
gated the associations between practice characteristics and
prescribing of PPIs. Our study does not clarify why older
GPs to a greater extent prescribe long-term treatment
with PPIs in first-time users, but it is important to keep in
mind that few single-handed practices are run by younger
GPs (Table 1). These practices could have a smaller long-
term user proportion due to random variation, decreasing
the comparability between younger and older GPs in
single-handed practices. Nevertheless, in line with our
findings it has been demonstrated that older GPs have
higher prescribing rates [14, 31, 32] and lower rates of
non-pharmacological treatments [14]. Similar to our
analyses, other studies have found that GPs of male gen-
der have higher prescribing rates [31, 33]. This could be
due to the traditional thought of female GPs being more
Table 3 Crude and adjusted odds ratios (OR) with 95 % confidence intervals (CI) for the association between characteristics of
single-handed practices and initiating long-term treatment with PPIs
Crude OR (95 % CI) P-value Adjusted OR* (95 % CI) P-value
Patients per GP
<1350 1 . 1 .
1350-1575 0.96 (0.84;1.11) 0.60 1.02 (0.88;1.17) 0.81
1576-1750 0.95 (0.83;1.09) 0.45 1.07 (0.92;1.23) 0.38
>1750 0.91 (0.80;1.03) 0.13 1.04 (0.91;1.20) 0.53
Practice location
Capital area 1 . 1 .
Provincial city 1.08 (0.98;1.19) 0.13 1.06 (0.96;1.17) 0.29
Rural area 1.18 (1.06;1.31) <0.001 1.05 (0.94;1.18) 0.37
GP gender
Male 1 . 1 .
Female 0.79 (0.72;0.87) <0.001 0.89 (0.81;0.99) 0.03
GP age group
Under 45 years 1 . 1 .
45-49 years 1.02 (0.80;1.30) 0.88 0.95 (0.73;1.22) 0.67
50-54 years 1.02 (0.82;1.27) 0.83 0.96 (0.77;1.21) 0.74
55-59 years 1.19 (0.97;1.45) 0.10 1.11 (0.90;1.37) 0.35
60-64 years 1.39 (1.14;1.71) <0.001 1.26 (1.02;1.56) 0.03
65 years or above 1.38 (1.12;1.71) <0.001 1.29 (1.03;1.62) 0.03
Training practice
No 1 . 1 .
Yes 0.96 (0.87;1.07) 0.46 0.96 (0.86;1.07) 0.45
*Estimates adjusted for practice characteristics and patient characteristics in terms of age, gender, specific gastrointestinal morbidity, socioeconomic status (income,
educational level, cohabitation status), comedication with non-steroidal anti-inflammatory drugs (NSAIDs), antiplatelet drugs, anticoagulants, selective serotonine reuptake
inhibitors (SSRIs) and comorbidity
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psychosocially orientated and more patient-centred com-
pared to male GPs [34, 35].
In the multivariate analyses we found no association
between single-handed practices and high rate of initiat-
ing long-term prescribing of PPIs. In some studies part-
nership practices have been associated with higher
scores for quality of care in chronic diseases [12, 36], al-
though the opposite has been shown as well [37, 38].
Moreover, patient satisfaction seems to be higher in
single-handed practices [39]. However, in the present
study we cannot determine either quality of care or pa-
tient satisfaction.
Being a training practice has also been shown to influ-
ence management of patients and quality of care [12, 40].
In our study we saw no association between training prac-
tice status and initiating long-term treatment with PPIs
except for partnership practices, where training practices
had slightly higher odds of initiating long-term treatment
(OR 1.08, CI 1.02-1.14). Why training practice status
influences partnership practices, but not single-handed
Table 4 Crude and adjusted odds ratios (OR) with 95 % confidence intervals (CI) for the association between characteristics of
partnership practices and initiating long-term treatment with PPIs
Crude OR (95 % CI) P-value Adjusted OR* (95 % CI) P-value
Patients per GP
<1350 1 . 1 .
1350-1575 1.00 (0.93;1.07) 0.94 0.99 (0.93;1.06) 0.83
1576-1750 0.95 (0.88;1.03) 0.19 0.98 (0.91;1.06) 0.69
>1750 0.95 (0.88;1.04) 0.27 0.98 (0.90;1.06) 0.61
Practice location
Capital area 1 . 1 .
Provincial city 1.01 (0.94;1.09) 0.75 0.98 (0.90;1.05) 0.53
Rural area 1.15 (1.06;1.24) <0.001 1.01 (0.94;1.10) 0.74
GP gender
Male 1 . 1 .
Predominantly male 0.82 (0.75;0.89) <0.001 0.85 (0.76;0.95) <0.001
Equally mixed 0.78 (0.71;0.85) <0.001 0.80 (0.73;0.87) <0.001
Predominantly female 0.77 (0.70;0.85) <0.001 0.83 (0.74;0.94) <0.001
Female 0.70 (0.62;0.79) <0.001 0.78 (0.69;0.88) <0.001
GP age group
Under 45 years 1 . 1 .
45-49 years 1.03 (0.92;1.15) 0.58 1.02 (0.91;1.14) 0.75
50-54 years 1.08 (0.97;1.21) 0.14 1.04 (0.93;1.15) 0.50
55-59 years 1.21 (1.08;1.35) <0.001 1.13 (1.01;1.26) 0.03
60-64 years 1.42 (1.23;1.63) <0.001 1.34 (1.16;1.54) <0.001
65 years or above 1.54 (1.26;1.87) <0.001 1.35 (1.11;1.64) <0.001
Number of GPs
2 1 . 1 .
3 0.96 (0.90;1.03) 0.26 0.95 (0.86;1.06) 0.37
4 0.96 (0.89;1.04) 0.36 0.99 (0.91;1.09) 0.91
5 0.98 (0.88;1.09) 0.71 0.96 (0.83;1.10) 0.52
>5 0.96 (0.85;1.10) 0.58 0.95 (0.82;1.10) 0.48
Training practice
No 1 . 1 .
Yes 1.07 (1.01;1.13) 0.03 1.08 (1.02;1.14) <0.001
*Estimates adjusted for practice characteristics and patient characteristics in terms of age, gender, specific gastrointestinal morbidity, socioeconomic status
(income, educational level, cohabitation status), comedication with non-steroidal anti-inflammatory drugs (NSAIDs), antiplatelet drugs, anticoagulants, selective
serotonine reuptake inhibitors (SSRIs) and comorbidity
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practices, is unknown. The association found is, however,
fairly weak and just barely statistically significant.
Rurality has been associated with higher rates of in-
appropriate prescribing [41] and different prescribing
patterns [42]. That we do not find similar associations
could be due to the fact that Denmark is a quite
homogenous country with small distances and less dif-
ference between rural and urban areas compared to
other countries.
Conclusion
Overall we conclude that there was significant variation
in initiating long-term treatment with PPIs between
practices. Some of this variation was associated with GP
characteristics despite part of the variation being due to
differences in characteristics of patient population. This
underlines the importance of taking patient characteris-
tics into account, when assessing associations between
GP characteristics and prescribing rates.
Whether or not initiating prescribing of long-term
treatment with PPIs reflects quality in the clinical setting
is challenging to determine in this study, but our results
indicate that older GPs and GPs of male gender might
have lower threshold for initiating long-term treatment
with PPIs, though the associations found were modest.
Some of the variation could be due to differences in
thoughts and knowledge about PPIs [43, 44]. The dem-
onstration of a variation does not in itself require inter-
ventions, but the findings could contribute to evidence-
based design of future interventions to enhance rational
prescribing of PPIs. The results call for reflection and
awareness of the fact that the care delivered is influ-
enced by the health care provider. To fully understand
the variations in initiating long-term use of PPIs, future
research could benefit from moving beyond the aggre-
gate associations and further explore the mental and so-
cial processes at work.
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